[Adjuvant medicinal treatment of stuttering].
D001533:Belladonna Alkaloids / Q000627:therapeutic use*; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D010634:Phenobarbital / Q000627:therapeutic use*; D013064:Speech Disorders / Q000628:therapy*; D013070:Speech Therapy; D013342:Stuttering
D001533:Belladonna Alkaloids; D004876:Ergot Alkaloids; D010634:Phenobarbital
BELLADONNA ALKALOIDS/therapeutic use; ERGOT ALKALOIDS/therapeutic use; PHENOBARBITAL/therapeutic use; SPEECH DISORDERS/therapy
Zur unterstützenden medikamentösen Behandlung des Stotterns.